
==== Front
Metabolomics
Metabolomics
Metabolomics
1573-3882
1573-3890
Springer US New York

2163
10.1007/s11306-024-02163-6
Original Article
High-quality identification of volatile organic compounds (VOCs) originating from breath
http://orcid.org/0009-0001-1207-5953
Arulvasan Wisenave wisenave.arulvasan@owlstone.co.uk

1
http://orcid.org/0000-0002-8028-225X
Chou Hsuan 1
Greenwood Julia 1
http://orcid.org/0000-0002-6150-0485
Ball Madeleine L. 1
Birch Owen 1
http://orcid.org/0009-0008-7347-844X
Coplowe Simon 1
http://orcid.org/0000-0002-8430-6220
Gordon Patrick 1
Ratiu Andreea 1
http://orcid.org/0000-0003-2273-1392
Lam Elizabeth 1
Hatch Ace 1
Szkatulska Monika 1
Levett Steven 1
Mead Ella 1
Charlton-Peel Chloe 1
Nicholson-Scott Louise 1
Swann Shane 1
http://orcid.org/0000-0001-8111-8198
van Schooten Frederik-Jan 2
Boyle Billy 1
Allsworth Max 1
1 grid.423318.f 0000 0004 4675 4668 Owlstone Medical Ltd, Cambridge, UK
2 https://ror.org/02jz4aj89 grid.5012.6 0000 0001 0481 6099 Faculty of Health, Medicine and Life Sciences, Pharmacology and Toxicology, Maastricht University, Maastricht, Netherlands
6 9 2024
6 9 2024
2024
20 5 10212 6 2024
10 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Introduction

Volatile organic compounds (VOCs) can arise from underlying metabolism and are detectable in exhaled breath, therefore offer a promising route to non-invasive diagnostics. Robust, precise, and repeatable breath measurement platforms able to identify VOCs in breath distinguishable from background contaminants are needed for the confident discovery of breath-based biomarkers.

Objectives

To build a reliable breath collection and analysis method that can produce a comprehensive list of known VOCs in the breath of a heterogeneous human population.

Methods

The analysis cohort consisted of 90 pairs of breath and background samples collected from a heterogenous population. Owlstone Medical’s Breath Biopsy® OMNI® platform, consisting of sample collection, TD-GC-MS analysis and feature extraction was utilized. VOCs were determined to be “on-breath” if they met at least one of three pre-defined metrics compared to paired background samples. On-breath VOCs were identified via comparison against purified chemical standards, using retention indexing and high-resolution accurate mass spectral matching.

Results

1471 VOCs were present in > 80% of samples (breath and background), and 585 were on-breath by at least one metric. Of these, 148 have been identified covering a broad range of chemical classes.

Conclusions

A robust breath collection and relative-quantitative analysis method has been developed, producing a list of 148 on-breath VOCs, identified using purified chemical standards in a heterogenous population. Providing confirmed VOC identities that are genuinely breath-borne will facilitate future biomarker discovery and subsequent biomarker validation in clinical studies. Additionally, this list of VOCs can be used to facilitate cross-study data comparisons for improved standardization.

Supplementary Information

The online version contains supplementary material available at 10.1007/s11306-024-02163-6.

Keywords

Volatile organic compounds (VOCs)
Breath analysis
Metabolome
Volatile metabolites
Non-invasive biomarkers
Breathomics
issue-copyright-statement© Springer Science+Business Media, LLC, part of Springer Nature 2024
==== Body
pmcIntroduction

Untargeted metabolomics based on mass spectrometry (MS) can provide insight into human health and disease that may not be apparent using nucleic acid or protein-based analytical approaches (Babu & Snyder, 2023). While metabolomic studies primarily focus on aqueous metabolites in samples such as blood, urine, and feces, breath is a rich and diverse matrix containing thousands of different volatile organic compounds (VOCs) (Costello et al., 2014; Haworth et al., 2022). The non-invasive nature of breath sampling makes it particularly attractive for clinical applications, such as early diagnosis and ongoing longitudinal monitoring.

However, the validation of clinically useful breath biomarkers remains limited. This is likely due, at least in part, to the lack of consistent methodologies and quality controls across the breath research literature (Issitt et al., 2022; Jia et al., 2019). To advance the field of breath analysis, there is an urgent need to develop a robust platform that can accurately identify the VOCs considered to be genuinely originating from the breath (which are comprised of endogenous VOCs derived from metabolic processes and exogenous VOCs, such as microbiome or dietary compounds). These breath-borne VOCs need to be distinguished from background VOCs that arise from the sampling equipment and surrounding air that was inhaled immediately before sampling, which are unrelated to underlying physiology. Establishing an accurate and repeatable methodology will expedite the identification and validation of VOC biomarkers of disease in future studies.

There are multiple approaches for collecting and analyzing breath, each with different advantages, limitations, and challenges (Haworth et al., 2022). Untargeted breath biomarker discovery workflows are most common, which often produce data on unknown VOCs or VOCs tentatively identified by comparison with publicly available standard libraries, such as those provided by the National Institute of Standards and Technology (NIST). This increases the risk of misidentifications due to differences in methodology and instrumentation between untargeted datasets and reference libraries, impeding the replication and validation of findings. Accurate identification of the VOCs in a breath sample requires a comparison to purified chemical standards analyzed using the same instrumentation and methods (Fiehn et al., 2007; Sumner et al., 2007). At least one unique chemical standard is required for every VOC to be identified, but as this is costly and time-consuming, many studies forego this critical process.

Another unmet need in the breath field is standardized methods for background correction (Herbig & Beauchamp, 2014). Many reports have noted the significance of background contributions to the VOCs observed in breath samples, which can originate from multiple potential sources such as ambient air or from breath sample collection equipment (Di Gilio et al., 2020; Westphal et al., 2022). Common background correction techniques in breath analysis include the calculation of an alveolar gradient to identify VOCs that are more abundant in breath (Phillips, 1997), or using a lung washout with synthetic air to identify VOCs likely to be contributed by inhaled background (Hewitt et al., 2022; Maurer et al., 2014; Schubert et al., 2005; Spaněl et al., 2013; Westhoff et al., 2022). However, the success of background correction relies heavily on the quality of the background measurement. One commonly used method for background measurements is to take a sample of ambient air in the same location where breath sampling is being performed, which neglects compounds originating from the sampling equipment. Since VOCs are ubiquitous in the environment and therefore can be introduced through multiple components and points throughout the analytical process (Pham et al., 2023), it is important to ensure comparable collection and handling of breath and background samples, of which there is already a method that has been previously described for the ReCIVA® breath Sampler (Di Gilio et al., 2020; Doran et al., 2017).

Other attempts have been made to develop a compendium of breath biomarkers (Drabińska et al., 2021; Kuo et al., 2020) which are useful assemblies and distillations of the important literature in this field. However, they also have the same limitations as the underlying literature. A general lack of standardization in sampling, analysis, and identification of VOCs means that it is difficult to quickly assign confidence to any single observation without reviewing the underlying literature. In this study, we present a novel methodology that combines robust breath and background collection, analytical distinguishing breath VOCs from background contamination, and VOC identification against chemical standards. We demonstrate the capability of this method by presenting a list of high-confidence breath VOCs identified from a heterogeneous human population.

Methods

Study design and subjects

This observational study was approved by the Reading Independent Ethics Committee RIEC: 290620-1, all participants provided written informed consent. Adults (≥ 18 years; Cambridge, UK) recruited all met the inclusion criteria, were free of active respiratory infection symptoms or diagnoses (including COVID-19) and fasted for at least two hours prior to breath sampling. We also decided to include some volunteers with various chronic diseases to account for potential normal variation in the population, and ensure breadth of VOC detection. All subjects were treated as a single cohort in statistical analysis as the study’s intention was not to compare differences between disease and control. Breath samples were collected from 99 adult volunteers between January and February 2022. Nine samples were excluded due to saliva contamination (determined by observation of saliva/bubbles within the tube) (n = 8) or incomplete collection volume (n = 1). The final analysis consisted of 90 breath samples and 90 paired system backgrounds (Table 1). Of the 90 adult subjects, 24 had some type of chronic disease including type 2 diabetes, high blood pressure, arthritis, and irritable bowel syndrome.

Table 1 Study cohort demographics. A breakdown of the total sample sizes (n) is shown along the top row, split into columns by the overall cohort, and then divided by sex (male and female). The mean age, BMI, and standard deviation (SD) for the cohort are shown in the top two rows. The total n and different percentages (%) of the cohort for smoking status and ethnicity are shown in subsequent rows, with finer breakdowns outlined

Variable	Overall	Female	Male	P-value	
Total N	90	48	42	N/A	
Age, mean (SD)	44.0 (16.6)	44.1 (16.7)	44.0 (16.6)	0.961	
BMI, mean (SD)	26.2 (6.0)	26.6 (7.2)	25.8 (4.2)	0.515	
Smoking Status, n (%)	Current Smoker	5 (5.5%)	2 (4.2%)	3 (7.2%)	0.521	
Ex-Smoker	21 (23.3%)	11 (22.9%)	10 (23.8%)	
Never Smoker	64 (71.1%)	35 (72.9%)	29 (69.0%)	
Ethnicity, n (%)	Caucasian	62 (68.9%)	33 (68.8%)	29 (69.0%)	0.900	
South Asian	12 (13.3%)	6 (12.5%)	6 (14.3%)	
East Asian	9 (10.0%)	6 (12.5%)	3 (7.1%)	
Black	5 (5.6%)	2 (4.2%)	3 (7.1%)	
Mixed Race	2 (2.2%)	1 (2.1%)	1 (2.4%)	

Breath sampling and analysis

The methodology utilized as part of this study is known as the Owlstone Medical Novel Insights (OMNI) method, and will be described in this section. Breath samples were collected using Owlstone Medical’s ReCIVA® Breath Sampler. The ReCIVA Breath Sampler pre-concentrates breath samples onto adsorbent tubes, enabling a larger collection of air volume and offering the potential for greater sensitivity in detecting low-abundance compounds. Subjects breathed normally into the ReCIVA mouthpiece with a nose plug (Supplementary Fig. 1). Approximately 1.25 L of breath are collected onto each sorbent tube – with the analysis completed with 2.5 L: 2 tubes for analysis and 2 tubes for backup. This meant a total of 5 L of breath was collected per participant. This takes approximately 12–15 min of normal tidal breathing into the device to collect.

Ambient contamination was minimized using the CASPER® Portable Air Supply during breath sampling, which filters ambient air into the ReCIVA (Supplementary Fig. 1). The CASPER is a portable air supply that takes in room air, filters it to remove VOCs and particulates, and supplies it directly into the ReCIVA Breath Sampler for a subject to breathe into. The CASPER removes VOCs using a replaceable air filter pack that is filled with activated carbon; VOCs from the ambient air are adsorbed to the surface of the carbon. These tools combined were used to collect VOCs produced from the subject and eliminate VOCs that are re-breathed directly from the air in the room. Equal volumes of matched system background samples were collected immediately before each breath sample. Using internal, fast response pressure sensors, the ReCIVA Breath Sampler can monitor patient breathing patterns in real-time (see Supplementary Fig. 1). Alongside the paired software, these sensors estimate when the end-tidal fraction of breath is being exhaled, and the sampling pumps are automatically turned on and off at the necessary time to collect that breath fraction. For background samples, all collection hardware was configured as if to collect a breath sample, but with the mouthpiece opening sealed and the software configured to sample continuously (no selection for specific fractions of breath). The exact settings are detailed in Supplementary Table 1.

Breath and background samples were analyzed using the Breath Biopsy OMNI settings (see Supplementary Materials for more details). The tubes were purged with a TD-100 (Markes International Ltd. Llantrisant, UK) and stored at a temperature of 4–8 °C for no more than 27 days before analysis. Breath and their paired background samples were liquid injected with a mix of eight deuterated internal standard compounds (Supplementary Table 2) solubilized in methanol and analyzed in the same sequence using TD-GC-MS. A series of straight-chain alkanes (C5-C16) were spiked onto a separate tube (50ng per alkane) and analyzed within each analytical sequence, to enable the calculation of retention indices. Analysis was conducted on the TD (Markes) – Q exactive Orbitrap (Thermo Fisher Scientific) high-resolution accurate mass spectrometry platform, utilizing the settings specified in Supplementary Table 3.

ReCIVA and CASPER breath collection, paired background sampling, TD-GC-MS analysis, and the feature extraction method are collectively known as the ‘OMNI’ method.

Feature extraction and data normalization

The resulting breath and background chromatograms (an example of a breath chromatogram is shown in Supplementary Fig. 2) were batch processed (spectral deconvolution, feature group clustering, and library matching to NIST17) utilizing the OMNI untargeted feature extraction method in Compound Discoverer (ver. 3.2, Thermo Scientific™), detailed in Supplementary Table 4. After feature extraction, all features were normalized using the measured peak area intensity response of spiked internal standard (IS) compounds to reduce analytical variability associated with TD-GC-MS. A hybrid correlation-retention time normalization method was applied, where the Pearson correlation coefficients between each feature in each sample and every IS compound were calculated. Features that had a correlation coefficient ≥ 0.8 with any IS compound were normalized using that IS compound’s response. When correlations for a given feature were below 0.8 for all ISs, the mean peak area response of the three IS compounds with the closest retention times to the feature was used for normalization.

Calculations comparing breath and paired system background samples

The three metrics were used to compare VOCs in breath samples and paired system background samples:

The standard deviation (SD) metric: A VOC was considered on-breath if the signal exceeded the mean of the system background signal plus 3 SDs in at least 50% of the breath samples from the cohort. A VOC is automatically on-breath if values are observed in less than 4 system backgrounds. Additionally, a feature observed in breath samples was automatically regarded “on-breath” if its signal was observed in fewer than 4 system backgrounds samples only.

The paired T-test approach metric: A VOC was regarded as on-breath if the paired breath/ system background samples were associated with a fold difference ≥ 2 and paired t-test one-tailed p-value ≤ 0.05.

The Receiver Operating characteristic area under the curve [ROC-AUC] metric: A VOC was considered on-breath if the fold difference between breath and background was > 1, and the calculated ROC-AUC value was ≥ 0.8.

Each on-breath metric queries the VOC signal detected in breath samples, with respect to the system background, in different ways. This increases the confidence of a VOC’s assignment as “on-breath” if it is calculated as such, by multiple metrics.

VOC identification using chemical standards

The candidate identities of on-breath VOCs were determined by matching the breath data against the NIST library and cross-checked against the human metabolome database (HMDB) (Westhoff et al., 2022). All NIST matches with a similarity index (SI) Match Factor ≥ 500 were considered for confirmation using purified standards. All NIST matches with a similarity index (SI) Match Factor of 500 or higher were considered for confirmation using purified standards. This threshold was chosen to reduce the risk of missing true matches due to spectral differences between the NIST spectra and the experimental data. These differences can arise from variations in the analytical methods, instruments, and deconvolution parameters used to generate the spectra. Specifically, the in-house library data was generated using Orbitrap-MS, whereas the NIST spectra are based on quadrupole mass analyzer data. The VOCs with the highest SI score and present in the HMDB were prioritized. Additionally, a list of commonly reported VOCs with hypothesized biological relevance were compiled from a literature search and added to the candidate list.

A certified reference standard (minimum 95% purity) was sourced for each candidate compound and analyzed to generate spectra for matching against on-breath VOCs. Reference standards were dissolved in methanol, due to its suitability for GC-MS analysis in terms of expansion coefficient and solubility for each candidate compound. Two to sixteen standards were grouped into each mix using NIST17-reported retention index values to minimize co-elution risk. The prepared chemical mixes were then liquid injected onto Tenax TA-Carbograph-5TD sorbent tubes resulting in 50 ng on-tube mass per chemical and analyzed using the OMNI analytical method (see Supplementary) alongside a C5 to C16 straight chain alkane RI ladder.

Spectra for individual reference standards were identified by deconvolution (using Thermo Scientific GC Deconvolution plugin, using the peak detection settings in Supplementary Table 3) followed by cross-referencing with the NIST library (NIST 17 mainlib and replib). A background tube loaded with methanol was examined to ensure the peaks of interest were not derived from contamination during analytical processing. Mass spectral cleaning was performed to retain only the high-resolution accurate mass fragments suspected to derive from the reference standards. The final spectrum of each reference standard confirmed the on-breath VOC identities. Confirmation relied on the three breath chromatograms with the highest normalized peak area intensity demonstrating a successful match (forward and reverse similarity index (SI & RSI) above 800, retention index within +/- 2 units). Undetected candidate standards were re-analyzed at higher concentrations (150 ng on-tube mass) to increase detection probability.

Results

Distinguishing on-breath VOCs from background

Following the analysis of the 90 adult breath samples and paired system backgrounds using the OMNI method, 1471 unique features were present in ≥ 80% of breath samples. Three metrics, detailed in the Methods section, were applied to identify the subset of VOCs present in the breath at levels significantly above those in the system background (henceforth referred to as “on-breath”).

Figure 1A shows the total number of on-breath VOCs that were calculated using each of the 3 metrics. There is a significant overlap in the subset of on-breath features classified using each on-breath calculation metric. A total of 585 VOCs were identified as on-breath using any metric, and, of these, the majority (328/585 = 56%) were on-breath by all metrics. Metric 1 was the most stringent, with most (328/346 = 95%) of the features identified on-breath using metric 1 also on-breath by the other two metrics.

Metric 1 includes a flexible cut-off for the frequency of a VOC’s appearance on-breath at levels 3 SDs above background (Fig. 1B). In this analysis, a 50% frequency threshold was applied, restricting the subset of on-breath VOCs to 346 out of the total 1471 (22.3%) features (Fig. 1B). This threshold was chosen to emphasize the VOCs that are on-breath in the majority of samples but could be adjusted to accommodate other analyses. For example, if a more stringent threshold was deemed appropriate, fewer VOCs could be considered as on-breath.

The three metrics were chosen to provide complimentary insights into the potential composition of on-breath VOCs. Equally, metrics of differing stringencies, when combined into a panel of metrics, may give higher confidence to an on-breath identification. For example, being on-breath in multiple metrics at once, or in metrics with lower odds of a false positive may provide higher confidence that a VOC is indeed on breath, while still ensuring that a wide range of potentially on-breath VOCs are still captured by at least one metric.

Fig. 1 A - Venn diagram showing the numbers of VOCs classified as on-breath by each metric, along with the number of those VOCs that have been identified, in brackets. B - Bar chart showing the frequency with which individual VOCs are classified as on-breath across all samples using metric 1. The dotted line indicates the 50% threshold, restricting the number of on-breath VOCs above this cut-off to 346 of the 1471 total

Identified VOCs: chemical characteristics

A total of 148 (25% of 585 VOCs on-breath by any metric) VOCs were able to be assigned identities based on comparisons to reference standards analyzed on the same analytical method in this dataset. A total of 825 purified chemical standards were run to achieve this; 37% of NIST matches with SI scores over 800 were found to be the true identity of the on-breath VOC. Factors impeding the identification of the remaining on-breath features include poor matches against the NIST library due to differences in analytical methodologies used (as discussed above), logistical considerations (such as lack of standard availability, safety considerations and/or prohibitive cost) and potential spectral issues during deconvolution (such as co-elution or splitting), whereby the resulting VOC spectra may not be an accurate representation of a true compound. Possible avenues of further work to overcome these limitations include considering custom synthesis of standards not readily available off the shelf, along with applying tailored spectral deconvolution settings for the peak-rich regions of the breath sample chromatograms.

Of the 148 identified VOCs, 102 are on-breath by all three metrics, a single identified VOC is on-breath by metric 1 alone, three identified VOCs are on-breath by metric 2 alone, and nine identified VOCs are on-breath by metric 3 alone (Fig. 1A). A substantial portion of the on-breath VOCs that have been assigned formal identifications (29/148 = 19.6%) were not classified as on-breath by metric 1, but they were on-breath by both metric 2 and metric 3 (Fig. 1A). While the three metrics have substantial overlap in the VOCs they determine to be on-breath, each metric contributed unique entries to the final pool of identified on-breath VOCs and may be appropriate for different VOCs or study designs. Additionally, to include VOCs that are on-breath in only a subset of the population, due to their uniqueness to a particular demographic, a separate analysis was carried out whereby features’ on-breath status was calculated per collected demographic variable, by considering only the system background samples relevant to the specific sub-population. This resulted in 3 additional on-breath features: two unique to the age 70 + group (one of which was successfully identified as 1,3-Dimethylcyclohexane), and one unique to the 30 + BMI group.

A full list of the identities of the 148 on-breath VOCs are presented in Table 2.

Table 2 The table shows all 148 on-breath VOCs that were able to be confidently chemically identified in this study, along with their InChI key identifier and chemical classification. The criteria they passed (TRUE) and failed (FALSE) to be classified as on-breath by the three metrics is also shown. The compounds are sorted by alphabetical order of chemical class

					On-breath status	
On-breath VOC ID	InChI key	Class	Subclass	% of breath samples on-breath in by metric 1	Metric 1 (mean + std dev)	Metric 2 (paired t-test)	Metric 3 (ROC-AUC)	
Bromodichloromethane	FMWLUWPQPKEARP-UHFFFAOYSA-N	Alkyl halides	Halomethanes	41	FALSE	TRUE	TRUE	
Chlorodibromomethane	GATVIKZLVQHOMN-UHFFFAOYSA-N	Alkyl halides	Halomethanes	59	TRUE	TRUE	TRUE	
Allyl methyl disulfide	XNZOTQPMYMCTBZ-UHFFFAOYSA-N	Allyl sulfur compounds		27	FALSE	TRUE​	TRUE​	
Allyl methyl sulfide	NVLPQIPTCCLBEU-UHFFFAOYSA-N	Allyl sulfur compounds		96	TRUE	TRUE	TRUE	
Imidazole	RAXXELZNTBOGNW-UHFFFAOYSA-N	Azoles	Imidazoles	80	TRUE	TRUE	TRUE	
Thiazole	FZWLAAWBMGSTSO-UHFFFAOYSA-N	Azoles	Thiazoles	96	TRUE	TRUE	TRUE	
1,3-Dichlorobenzene	ZPQOPVIELGIULI-UHFFFAOYSA-N	Benzene and substituted derivatives	Halobenzenes	32	FALSE	FALSE	TRUE	
1,4-Dichlorobenzene	OCJBOOLMMGQPQU-UHFFFAOYSA-N	Benzene and substituted derivatives	Halobenzenes	24	FALSE	FALSE	TRUE​	
2,5-Dimethylstyrene	DBWWINQJTZYDFK-UHFFFAOYSA-N	Benzene and substituted derivatives	Styrenes	51	FALSE	TRUE​	TRUE​	
2,6-Diphenylphenol	ATGFTMUSEPZNJD-UHFFFAOYSA-N	Benzene and substituted derivatives	Terphenyls	68	TRUE	TRUE	TRUE	
2-Cyclohexylphenol	MVRPPTGLVPEMPI-UHFFFAOYSA-N	Benzene and substituted derivatives	Cyclohexylphenols	51	TRUE	TRUE	TRUE	
2-Phenylethanol	WRMNZCZEMHIOCP-UHFFFAOYSA-N	Benzene and substituted derivatives		42	FALSE	TRUE	TRUE	
Benzene	UHOVQNZJYSORNB-UHFFFAOYSA-N	Benzene and substituted derivatives		27	FALSE	TRUE	TRUE	
Chlorobenzene	MVPPADPHJFYWMZ-UHFFFAOYSA-N	Benzene and substituted derivatives	Halobenzenes	44	FALSE	TRUE	TRUE	
Cumene	RWGFKTVRMDUZSP-UHFFFAOYSA-N	Benzene and substituted derivatives	Cumenes	69	TRUE	TRUE	TRUE	
Fluorobenzene	PYLWMHQQBFSUBP-UHFFFAOYSA-N	Benzene and substituted derivatives	Halobenzenes	33	FALSE	TRUE	TRUE	
Isophthalaldehyde	IZALUMVGBVKPJD-UHFFFAOYSA-N	Benzene and substituted derivatives	Benzoyl derivatives	17	FALSE	FALSE	TRUE	
m-Cymene	XCYJPXQACVEIOS-UHFFFAOYSA-N	Benzene and substituted derivatives	Cumenes	87	TRUE	TRUE	TRUE	
Methyl salicylate	OSWPMRLSEDHDFF-UHFFFAOYSA-N	Benzene and substituted derivatives	Benzoic acids and derivatives	20	FALSE	TRUE	TRUE	
Phenylacetaldehyde	DTUQWGWMVIHBKE-UHFFFAOYSA-N	Benzene and substituted derivatives	Phenylacetaldehydes	18	FALSE	FALSE	TRUE	
Phenylhydroquinone	XCZKKZXWDBOGPA-UHFFFAOYSA-N	Benzene and substituted derivatives	Biphenyls and derivatives	46	FALSE	TRUE	TRUE	
Toluene	YXFVVABEGXRONW-UHFFFAOYSA-N	Benzene and substituted derivatives	Toluenes	12	FALSE	FALSE	TRUE	
2-Coumaranone	ACZGCWSMSTYWDQ-UHFFFAOYSA-N	Benzofurans		50	TRUE	TRUE	TRUE	
2-Methylbenzofuran	GBGPVUAOTCNZPT-UHFFFAOYSA-N	Benzofurans		21	FALSE	TRUE	TRUE	
Chromone	OTAFHZMPRISVEM-UHFFFAOYSA-N	Benzopyrans	1-benzopyrans	60	TRUE	FALSE	TRUE	
Galaxolide	ONKNPOPIGWHAQC-UHFFFAOYSA-N	Benzopyrans	2-benzopyrans	53	TRUE	TRUE	TRUE	
Formamide	ZHNUHDYFZUAESO-UHFFFAOYSA-N	Carboximidic acids and derivatives	Carboximidic acids	97	TRUE	TRUE	TRUE	
Acetic acid	QTBSBXVTEAMEQO-UHFFFAOYSA-N	Carboxylic acids and derivatives	Carboxylic acids	70	TRUE	TRUE	TRUE	
Methyl acetate	KXKVLQRXCPHEJC-UHFFFAOYSA-N	Carboxylic acids and derivatives	Carboxylic acid derivatives	98	TRUE	TRUE	TRUE	
Methyl acrylate	BAPJBEWLBFYGME-UHFFFAOYSA-N	Carboxylic acids and derivatives	Acrylic acids and derivatives	96	TRUE	TRUE	TRUE	
Methyl methacrylate	VVQNEPGJFQJSBK-UHFFFAOYSA-N	Carboxylic acids and derivatives	Carboxylic acid derivatives	3	FALSE	TRUE​	TRUE​	
N, N-Dimethylformamide	ZMXDDKWLCZADIW-UHFFFAOYSA-N	Carboxylic acids and derivatives	Carboxylic acid derivatives	20	FALSE	TRUE	TRUE	
N-Methylsuccinimide	KYEACNNYFNZCST-UHFFFAOYSA-N	Carboxylic acids and derivatives	Carboxylic acid derivatives	83	TRUE	TRUE	TRUE	
Propionamide	QLNJFJADRCOGBJ-UHFFFAOYSA-N	Carboxylic acids and derivatives	Carboxylic acid derivatives	67	TRUE	TRUE	TRUE	
Propionic acid	XBDQKXXYIPTUBI-UHFFFAOYSA-N	Carboxylic acids and derivatives	Carboxylic acids	62	TRUE	TRUE	TRUE	
Pyrazine	KYQCOXFCLRTKLS-UHFFFAOYSA-N	Diazines	Pyrazines	77	TRUE	TRUE	TRUE	
2,3-Dihydrofuran	JKTCBAGSMQIFNL-UHFFFAOYSA-N	Dihydrofurans		58	TRUE	TRUE	TRUE	
4-Methyl-2(5 H)-furanone	ZZEYQBNQZKUWKY-UHFFFAOYSA-N	Dihydrofurans	Furanones	84	TRUE	TRUE	TRUE	
1,4-Dioxane	RYHBNJHYFVUHQT-UHFFFAOYSA-N	Dioxanes	1,4-dioxanes	90	TRUE	TRUE	TRUE	
1,4-Dioxene	HIZVCIIORGCREW-UHFFFAOYSA-N	Dioxins	Para dioxins	44	FALSE	TRUE​	TRUE​	
2-Methyl-1,3-dioxolane	HTWIZMNMTWYQRN-UHFFFAOYSA-N	Dioxolanes	1,3-dioxolanes	79	TRUE	TRUE	TRUE	
1-Hexadecanol	BXWNKGSJHAJOGX-UHFFFAOYSA-N	Fatty Acyls	Fatty alcohols	56	TRUE	TRUE	TRUE	
Isopropyl myristate	AXISYYRBXTVTFY-UHFFFAOYSA-N	Fatty Acyls	Fatty acid esters	19	FALSE	FALSE	TRUE	
Isopropyl palmitate	XUGNVMKQXJXZCD-UHFFFAOYSA-N	Fatty Acyls	Fatty acid esters	61	TRUE	TRUE	TRUE	
Methyl furan-3-carboxylate	ZKHQSQYLKSSYIP-UHFFFAOYSA-N	Furans	Furoic acid and derivatives	90	TRUE	TRUE	TRUE	
2,3,5-Trimethylfuran	NJXZFRUNHWKHEC-UHFFFAOYSA-N	Heteroaromatic compounds		98	TRUE	TRUE	TRUE	
2,5-Dimethylfuran	GSNUFIFRDBKVIE-UHFFFAOYSA-N	Heteroaromatic compounds		96	TRUE	TRUE	TRUE	
2-Furonitrile	YXDXXGXWFJCXEB-UHFFFAOYSA-N	Heteroaromatic compounds		96	TRUE	TRUE	TRUE	
2-Methylfuran	VQKFNUFAXTZWDK-UHFFFAOYSA-N	Heteroaromatic compounds		98	TRUE	TRUE	TRUE	
3-Methylthiophene	QENGPZGAWFQWCZ-UHFFFAOYSA-N	Heteroaromatic compounds		98	TRUE	TRUE	TRUE	
Pyrrole	KAESVJOAVNADME-UHFFFAOYSA-N	Heteroaromatic compounds		92	TRUE	TRUE	TRUE	
3-Methylindole	ZFRKQXVRDFCRJG-UHFFFAOYSA-N	Indoles and derivatives	Indoles	93	TRUE	TRUE	TRUE	
Indole	SIKJAQJRHWYJAI-UHFFFAOYSA-N	Indoles and derivatives	Indoles	97	TRUE	TRUE	TRUE	
gamma-Valerolactone	GAEKPEKOJKCEMS-UHFFFAOYSA-N	Lactones	Gamma butyrolactones	57	TRUE	TRUE	TRUE	
1,3-Dioxol-2-one	VAYTZRYEBVHVLE-UHFFFAOYSA-N	Organic carbonic acids and derivatives	Carbonic acid diesters	66	TRUE	TRUE	TRUE	
Dimethyl disulfide	WQOXQRCZOLPYPM-UHFFFAOYSA-N	Organic disulfides	Dialkyldisulfides	98	TRUE	TRUE	TRUE	
Dimethyl trisulfide	YWHLKYXPLRWGSE-UHFFFAOYSA-N	Organic trisulfides		92	TRUE	TRUE	TRUE	
1,1,1-Trichloroethane	UOCLXMDMGBRAIB-UHFFFAOYSA-N	Organochlorides		14	FALSE	TRUE	TRUE	
Dodecamethylcyclohexasiloxane	IUMSDRXLFWAGNT-UHFFFAOYSA-N	Organometalloid compounds	Organosilicon compounds	29	FALSE	TRUE	TRUE	
Hexadecamethylheptasiloxane	NFVSFLUJRHRSJG-UHFFFAOYSA-N	Organometalloid compounds	Organosilicon compounds	50	TRUE	TRUE	TRUE	
Acetonitrile	WEVYAHXRMPXWCK-UHFFFAOYSA-N	Organonitrogen compounds	Organic cyanides	16	FALSE	TRUE	TRUE	
Trimethylamine	GETQZCLCWQTVFV-UHFFFAOYSA-N	Organonitrogen compounds	Amines	91	TRUE	TRUE	TRUE	
1-Propanol	BDERNNFJNOPAEC-UHFFFAOYSA-N	Organooxygen compounds	Alcohols and polyols	57	TRUE	TRUE	TRUE	
2-(2-Methoxyethoxy)ethanol	SBASXUCJHJRPEV-UHFFFAOYSA-N	Organooxygen compounds	Ethers	59	TRUE	TRUE	TRUE	
2,3-Butanediol	OWBTYPJTUOEWEK-UHFFFAOYSA-N	Organooxygen compounds	Alcohols and polyols	73	TRUE	TRUE	TRUE	
2,3-Butanedione	QSJXEFYPDANLFS-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	74	TRUE	TRUE	#REF!	
2-Acetyl-5-methylfuran	KEFJLCGVTHRGAH-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	93	TRUE	TRUE	TRUE	
2-Acetylfuran	IEMMBWWQXVXBEU-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	96	TRUE	TRUE	TRUE	
2-Acetylpyridine	AJKVQEKCUACUMD-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	68	TRUE	TRUE	TRUE	
2’-Hydroxyacetophenone	JECYUBVRTQDVAT-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	87	TRUE	TRUE	TRUE	
2-Methoxyethanol	XNWFRZJHXBZDAG-UHFFFAOYSA-N	Organooxygen compounds	Ethers	62	TRUE	TRUE	TRUE	
2-Methyl-2-butenal	ACWQBUSCFPJUPN-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	98	TRUE	TRUE	TRUE	
2-Methyl-3-buten-2-ol	HNVRRHSXBLFLIG-UHFFFAOYSA-N	Organooxygen compounds	Alcohols and polyols	91	TRUE	TRUE	TRUE	
2-Pentanone	XNLICIUVMPYHGG-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	96	TRUE	TRUE	TRUE	
2-Propenol	XXROGKLTLUQVRX-UHFFFAOYSA-N	Organooxygen compounds	Alcohols and polyols	32	FALSE	TRUE	TRUE	
3-Buten-2-one	FUSUHKVFWTUUBE-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	99	TRUE	TRUE	TRUE	
3-Thiophenecarboxaldehyde	RBIGKSZIQCTIJF-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	96	TRUE	TRUE	TRUE	
4-Heptanone	HCFAJYNVAYBARA-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	92	TRUE	TRUE	TRUE	
5-Methylfurfural	OUDFNZMQXZILJD-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	84	TRUE	TRUE	TRUE	
Acetaldehyde	IKHGUXGNUITLKF-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	47	FALSE	TRUE	TRUE	
Acetone	CSCPPACGZOOCGX-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	88	TRUE	TRUE	TRUE	
Benzofuran-2-yl(phenyl)methanone	DZRJNLPOTUVETG-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	26	FALSE	TRUE	TRUE	
Diethylene glycol monoethyl ether	XXJWXESWEXIICW-UHFFFAOYSA-N	Organooxygen compounds	Ethers	61	TRUE	TRUE	TRUE	
Ethylene glycol	LYCAIKOWRPUZTN-UHFFFAOYSA-N	Organooxygen compounds	Alcohols and polyols	47	FALSE	TRUE	TRUE	
Furan-2,5-dicarbaldehyde	PXJJKVNIMAZHCB-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	17	FALSE	FALSE	TRUE	
Furfural	HYBBIBNJHNGZAN-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	19	FALSE	FALSE	TRUE	
Methacrolein	STNJBCKSHOAVAJ-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	99	TRUE	TRUE	TRUE	
Phenacyl acetate	BGAXCPSNMHVHJC-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	50	TRUE	TRUE	TRUE	
Propylene glycol	DNIAPMSPPWPWGF-UHFFFAOYSA-N	Organooxygen compounds	Alcohols and polyols	33	FALSE	TRUE	FALSE	
Pyrrole-2-carboxaldehyde	ZSKGQVFRTSEPJT-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	80	TRUE	TRUE	TRUE	
Salicylaldehyde	SMQUZDBALVYZAC-UHFFFAOYSA-N	Organooxygen compounds	Carbonyl compounds	73	TRUE	TRUE	TRUE	
Triethylene glycol monomethyl ether	JLGLQAWTXXGVEM-UHFFFAOYSA-N	Organooxygen compounds	Ethers	47	FALSE	TRUE	FALSE	
Carbon disulfide	QGJOPFRUJISHPQ-UHFFFAOYSA-N	Other non-metal organides	Other non-metal sulfides	73	TRUE	TRUE	TRUE	
Eucalyptol	WEEGYLXZBRQIMU-UHFFFAOYSA-N	Oxanes		94	TRUE	TRUE	TRUE	
1,6-Anhydro-beta-D-galactose	TWNIBLMWSKIRAT-UHFFFAOYSA-N	Oxepanes		32	FALSE	TRUE	FALSE	
Phenalen-1-one	WWBGWPHHLRSTFI-UHFFFAOYSA-N	Phenalenes	Phenalenones	34	FALSE	TRUE	TRUE	
2-(3-Methylphenoxy)ethanol	FDBXUXVQIOQYIX-UHFFFAOYSA-N	Phenol ethers		77	TRUE	TRUE	TRUE	
Anethole	RUVINXPYWBROJD-UHFFFAOYSA-N	Phenol ethers	Anisoles	86	TRUE	TRUE	TRUE	
4-Ethylphenol	HXDOZKJGKXYMEW-UHFFFAOYSA-N	Phenols	1-hydroxy-2-unsubstituted benzenoids	76	TRUE	TRUE	TRUE	
Guaiacol	LHGVFZTZFXWLCP-UHFFFAOYSA-N	Phenols	Methoxyphenols	67	TRUE	TRUE	TRUE	
Hydroquinone	QIGBRXMKCJKVMJ-UHFFFAOYSA-N	Phenols	Benzenediols	39	FALSE	TRUE	TRUE	
o-Cresol	QWVGKYWNOKOFNN-UHFFFAOYSA-N	Phenols	Cresols	71	TRUE	TRUE	TRUE	
Phenol	ISWSIDIOOBJBQZ-UHFFFAOYSA-N	Phenols	1-hydroxy-4-unsubstituted benzenoids	97	TRUE	TRUE	TRUE	
1,4-Cineole	RFFOTVCVTJUTAD-UHFFFAOYSA-N	Prenol lipids	Monoterpenoids	28	FALSE	TRUE	TRUE	
3-Carene	BQOFWKZOCNGFEC-UHFFFAOYSA-N	Prenol lipids	Monoterpenoids	82	TRUE	TRUE	TRUE	
alpha-Curcumene	VMYXUZSZMNBRCN-UHFFFAOYSA-N	Prenol lipids	Sesquiterpenoids	21	FALSE	TRUE	FALSE	
alpha-Pinene	GRWFGVWFFZKLTI-UHFFFAOYSA-N	Prenol lipids	Monoterpenoids	96	TRUE	TRUE	TRUE	
alpha-Thujene	KQAZVFVOEIRWHN-UHFFFAOYSA-N	Prenol lipids	Monoterpenoids	63	TRUE	TRUE	TRUE	
beta-Phellandrene	LFJQCDVYDGGFCH-UHFFFAOYSA-N	Prenol lipids	Monoterpenoids	83	TRUE	TRUE	TRUE	
beta-Pinene	WTARULDDTDQWMU-UHFFFAOYSA-N	Prenol lipids	Monoterpenoids	93	TRUE	TRUE	TRUE	
Caryophyllene	NPNUFJAVOOONJE-UHFFFAOYSA-N	Prenol lipids	Sesquiterpenoids	60	FALSE	TRUE	TRUE	
Limonene	XMGQYMWWDOXHJM-UHFFFAOYSA-N	Prenol lipids	Monoterpenoids	87	TRUE	TRUE	TRUE	
Menthofuran	YGWKXXYGDYYFJU-UHFFFAOYSA-N	Prenol lipids	Monoterpenoids	76	TRUE	TRUE	TRUE	
Ocimene	IHPKGUQCSIINRJ-UHFFFAOYSA-N	Prenol lipids	Monoterpenoids	60	TRUE	TRUE	TRUE	
p-Menthan-3-one	NFLGAXVYCFJBMK-UHFFFAOYSA-N	Prenol lipids	Monoterpenoids	73	TRUE	TRUE	TRUE	
Valencene	QEBNYNLSCGVZOH-UHFFFAOYSA-N	Prenol lipids	Sesquiterpenoids	47	FALSE	TRUE	TRUE	
2-Methylpyridine	BSKHPKMHTQYZBB-UHFFFAOYSA-N	Pyridines and derivatives	Methylpyridines	94	TRUE	TRUE	TRUE	
3-Methylpyridine	ITQTTZVARXURQS-UHFFFAOYSA-N	Pyridines and derivatives	Methylpyridines	90	TRUE	TRUE	TRUE	
3-Pyridinecarboxaldehyde	QJZUKDFHGGYHMC-UHFFFAOYSA-N	Pyridines and derivatives	Pyridine carboxaldehydes	83	TRUE	TRUE	TRUE	
Pyridine	JUJWROOIHBZHMG-UHFFFAOYSA-N	Pyridines and derivatives		88	TRUE	TRUE	TRUE	
1-Methylpyrrole	OXHNLMTVIGZXSG-UHFFFAOYSA-N	Pyrroles	Substituted pyrroles	54	TRUE	TRUE	TRUE	
2-Methyl-1 H-pyrrole	TVCXVUHHCUYLGX-UHFFFAOYSA-N	Pyrroles	Substituted pyrroles	23	FALSE	TRUE	TRUE	
1,1,3-Trimethylcyclohexane	PYOLJOJPIPCRDP-UHFFFAOYSA-N	Saturated hydrocarbons	Cycloalkanes	16	FALSE	TRUE	TRUE	
Heptane	IMNFDUFMRHMDMM-UHFFFAOYSA-N	Saturated hydrocarbons	Alkanes	12	FALSE	TRUE	TRUE	
Nonane	BKIMMITUMNQMOS-UHFFFAOYSA-N	Saturated hydrocarbons	Alkanes	17	FALSE	TRUE	TRUE	
Octane	TVMXDCGIABBOFY-UHFFFAOYSA-N	Saturated hydrocarbons	Alkanes	49	FALSE	TRUE	TRUE	
Diphenylmaleic anhydride	OUJCFCNZIUTYBH-UHFFFAOYSA-N	Stilbenes		29	FALSE	TRUE	TRUE	
Dimethyl sulfoxide	IAZDPXIOMUYVGZ-UHFFFAOYSA-N	Sulfoxides		80	TRUE	FALSE	TRUE	
Tetrahydrofuran	WYURNTSHIVDZCO-UHFFFAOYSA-N	Tetrahydrofurans		28	FALSE	FALSE	TRUE	
Bis(methylthio)methane	LOCDPORVFVOGCR-UHFFFAOYSA-N	Thioacetals	Dithioacetals	93	TRUE	FALSE	FALSE	
Methyl thiocyanate	VYHVQEYOFIYNJP-UHFFFAOYSA-N	Thiocyanates		98	TRUE	TRUE	TRUE	
Dimethyl sulfide	QMMFVYPAHWMCMS-UHFFFAOYSA-N	Thioethers	Dialkylthioethers	97	TRUE	TRUE	TRUE	
Methyl propyl sulfide	ZOASGOXWEHUTKZ-UHFFFAOYSA-N	Thioethers	Dialkylthioethers	96	TRUE	TRUE	TRUE	
Methenamine	VKYKSIONXSXAKP-UHFFFAOYSA-N	Triazinanes	1,3,5-triazinanes	93	TRUE	TRUE	TRUE	
1,3,5-Triazine	JIHQDMXYYFUGFV-UHFFFAOYSA-N	Triazines	1,3,5-triazines	90	TRUE	TRUE	TRUE	
1-Butene	VXNZUUAINFGPBY-UHFFFAOYSA-N	Unsaturated hydrocarbons	Unsaturated aliphatic hydrocarbons	72	TRUE	TRUE	TRUE	
1-Docosene	SPURMHFLEKVAAS-UHFFFAOYSA-N	Unsaturated hydrocarbons	Unsaturated aliphatic hydrocarbons	48	FALSE	TRUE​	TRUE​	
1-Methylcyclopentene	ATQUFXWBVZUTKO-UHFFFAOYSA-N	Unsaturated hydrocarbons	Branched unsaturated hydrocarbons	56	TRUE	FALSE	TRUE	
2-Pentene	QMMOXUPEWRXHJS-UHFFFAOYSA-N	Unsaturated hydrocarbons	Unsaturated aliphatic hydrocarbons	32	FALSE	TRUE	TRUE	
3-Methyl-1-butene	YHQXBTXEYZIYOV-UHFFFAOYSA-N	Unsaturated hydrocarbons	Unsaturated aliphatic hydrocarbons	59	TRUE	TRUE	TRUE	
3-Methyl-2-pentene	BEQGRRJLJLVQAQ-UHFFFAOYSA-N	Unsaturated hydrocarbons	Branched unsaturated hydrocarbons	74	TRUE	TRUE	TRUE	
Cyclohexene	HGCIXCUEYOPUTN-UHFFFAOYSA-N	Unsaturated hydrocarbons	Olefins	56	TRUE	TRUE	TRUE	
Cyclopentene	LPIQUOYDBNQMRZ-UHFFFAOYSA-N	Unsaturated hydrocarbons	Olefins	90	TRUE	TRUE	TRUE	
gamma-Terpinene	YKFLAYDHMOASIY-UHFFFAOYSA-N	Unsaturated hydrocarbons	Branched unsaturated hydrocarbons	93	TRUE	TRUE	TRUE	
Isoprene	RRHGJUQNOFWUDK-UHFFFAOYSA-N	Unsaturated hydrocarbons	Branched unsaturated hydrocarbons	99	TRUE	TRUE	TRUE	
Isopropenylacetylene	BOFLDKIFLIFLJA-UHFFFAOYSA-N	Unsaturated hydrocarbons	Branched unsaturated hydrocarbons	88	TRUE	TRUE	TRUE	
Penta-1,3-diene	PMJHHCWVYXUKFD-UHFFFAOYSA-N	Unsaturated hydrocarbons	Olefins	79	TRUE	TRUE	TRUE	
Tetrachloroethylene	CYTYCFOTNPOANT-UHFFFAOYSA-N	Vinyl halides	Vinyl chlorides	71	TRUE	TRUE	TRUE	

Discussion

The challenges in studying breath VOCs are well-known in the research community. Healthy human breath profiles have been developed to understand how physiological conditions, including age, gender and circadian rhythms, can influence breath profiles (Sasiene et al., 2024). However, differentiation of on-breath compounds from background, and confirmation of their identities, remain major obstacles to advancing their applications in diagnostics and clinical settings. In this study, we present a list of 148 breath-associated (on-breath) chemically identified VOCs. The integrity of this data relies on stringent criteria for two key aspects: distinguishing VOCs from background contaminants and confirming their chemical identity. The on-breath VOCs presented in this study have been confidently chemically identified using MSI standards and were distinguishable from background contaminants through a robust methodology in a heterogenous human population (spanning a range of ages, BMIs, and ethnicities). On-breath VOCs span 45 chemical classes, indicating that they comprise a diverse pool of chemical entities, and 62% have been previously reported in the literature in different biological matrices such as blood, urine, and fecal matter. However, the identified VOCs may also not necessarily be consistent with other studies in the literature due to differences in populations and analytical methodologies utilized previously.

It is also imperative to emphasize that on-breath VOCs can include both endogenously and exogenously generated VOCs (as exogenous VOCs can be very strongly breath-associated, especially those generated from internal sources such as the gut microbiome). Although not produced by the body, exogenous on-breath VOCs can interact widely with the host metabolome and demonstrate powerful utility in bridging the gap between research tools and breath-based clinical applications. One such example is indole, which is generated by the catabolism of tryptophan, mediated by the human gut microbiome; elevated levels of indole observed in cirrhosis could be explained by impaired hepatic clearance, providing a plausible mechanistic relationship between a microbiome related VOC and a clinical diagnosis (Ferrandino et al., 2023). In terms of well-established clinical applications, the gold standard diagnostic test used in gut health clinics for small intestinal bacterial overgrowth (SIBO) involves the ingestion of an exogenous substrate (lactulose). If SIBO is present, this synthetic sugar is metabolized by bacteria in the small intestine to produce molecular hydrogen, detectable on breath. Similarly, limonene, a VOC generated by dietary exposure was observed to be elevated in the breath of subjects with cirrhosis compared to controls in multiple studies (Dadamio et al., 2012; Fernández del Río et al., 2015), suggesting that reduced liver function and impaired hepatic perfusion induce limonene accumulation in the body resulting in elevated levels in breath. These alterations make limonene a candidate biomarker for non-invasive cirrhosis detection using a breath test (Ferrandino et al., 2023).

Acetone, isoprene, and indole can be used as a starting point to assess the consistency of the results of this study with breath compositions reported elsewhere, as these are some of the most abundant and commonly identified breath VOCs (Drabińska et al., 2021). All three of these compounds were frequently found to be on-breath within this population, supporting the replicability of this study’s results. Isoprene has been associated previously with a broad range of disease states, however, there are doubts over how useful of a biomarker breath isoprene currently is due to the lack of specificity to certain disease states, and sensitivity to individual breathing patterns and movement (Mochalski et al., 2023). Breath isoprene has recently been mechanistically associated with skeletal muscle metabolic activity using a multi-omic approach (Sukul et al., 2023; Mochalski et al., 2024), demonstrating endogenous origin. The majority of breath isoprene is produced through the IDI2 protein that is only present within skeletal-myocellular peroxisomes (Sukul et al., 2023), and therefore supports the observation that breath isoprene abundance increases after exercise (Chou et al., 2024; Pugliese et al., 2022). This understanding of the body’s mechanistic origin has helped to associate isoprene with a specific physiological process and could help establish what clinically useful information could be gained by the use of breath isoprene as a biomarker.

As the current study only aimed to characterize the composition of normal human breath, the identified on-breath VOCs currently cannot suggest metabolic pathway changes, however, certain valuable insights can be gained. For example, acetic acid and propionic acid were both found to be on-breath and are two well-characterized short-chain fatty acids (SCFAs) associated with the gut microbiome. SCFAs are considered exogenous VOCs because they are produced by microbial fermentation of dietary fiber and are thought to diffuse into local blood vessels of the gastrointestinal tract, travel via the blood, and enter the breath through alveolar exchange. The microbially-formed gas hydrogen produced in the gastrointestinal tract is rapidly detectable in the breath through this mechanism, and is therefore currently used in the clinic to diagnose conditions such as small intestinal bacterial overgrowth (Pitcher et al., 2022; Read et al., 1985; Sachdev & Pimentel, 2013). The abundance level of SCFAs has been implicated in multiple health contexts, including cancer, neurogenerative disease, and inflammatory bowel disease (Duizer & de Zoete, 2023; Majumdar et al., 2023; Ney et al., n.d.; Parada Venegas et al., 2019; van Vorstenbosch et al., 2023; Wang et al., 2023). In addition, their multiple signaling roles have become increasingly appreciated for their potential impacts on human health (Louis & Flint, 2017; Miller & Wolin, 1996). Therefore, the SCFAs could serve as breath biomarkers of disease much like hydrogen and methane breath tests in the future. Their characterization on-breath and the development of reference ranges in a healthy population is essential for this development, of which this study provides a useful starting point.

Isoprene, acetic and propionic acid are examples of the connections between the identified on-breath compounds and the literature, but there have been many more associations with a broader range of these compounds with physiological processes in the literature, such as carbon disulfide, dimethyl sulfide, and dimethyl disulfide (Carrión et al., 2015; Di Cagno et al., 2011; Grabowska-Polanowska et al., 2017; Preter et al., 2015). While the mechanism behind the appearance of certain on-breath VOCs in this dataset remain unknown, crucially, their identities have been verified. This suggests that the discovery of novel pathways and a new understanding of physiological processes can occur if the levels of these VOCs are found to change in disease cohorts.

In this study, the system background samples were collected from the entire equipment flow path of air to capture all possible sources of VOC background in the sampling process. Moisture levels may differ between background samples and breath. Given that humidity and temperature are key variables for VOC capture, mitigations have been implemented to reduce this differential: hydrophobic sorbents are used in our TD tubes and all samples are dry purged prior to analysis. We acknowledge that this minimizes the carryover risk, but not the instantaneous risk. Despite our best efforts, breath and blank samples are ultimately different sample types and there may be small analytical differences introduced as a result. We did not consider this to have a major impact to the conclusions we draw from this article.

The analytical methodology utilized offers high mass accuracy and resolution capability, resulting in precise mass measurement of ions and separation of closely spaced mass peaks. These functionalities provided high specificity by accurately determining molecular formulas and distinguishing between different VOCs with similar masses, respectively, thereby increasing the accuracy of VOC identification. For background correction, this study built on the alveolar gradient approach and utilized three metrics to compare breath and background signals, which can account for the variability of VOCs in the samples while also being practical for field implementation. Stringent processes were applied to the identification of VOCs using reference standards run on the same analytical method and instrument, accurate mass (within 5 ppm tolerance) to compare fragmentation spectra, and an alkane ladder to enable a strict RI match. VOCs were only identified if they could be characterized as “on-breath” by pre-defined metrics used to compare breath to representative system background samples. These metrics are intended to capture the widest range of on-breath VOCs, while providing sufficient stringency. In the future, they can be used alone or in combination, depending on the study design and VOCs of interest. The multiple metrics not only expand our knowledge of common on-breath VOCs but also allow differentiation from background, increasing confidence when comparing VOCs across different study cohorts and methodologies.

Despite the stringent methodology used to exclude background contaminants, it is still likely that certain on-breath compounds arise from processes unrelated to underlying physiology. It is also possible that some breath VOCs may be currently below our effective detection limit due to the presence and variation of VOCs in the background, and systematically reducing background contamination could improve this. The list of on-breath VOCs provides a starting point for this work, as targeted analyses can help identify where background contamination may be reduced and which specific chemicals, or groups of chemicals are likely to be affected. Future work will expand the capabilities of detection via sampling onto different sorbent beds and using different GC-column chemistries, broadening the range of VOCs covered. This study included a heterogeneous cohort, enabling a comprehensive characterization of breath composition. It is likely that VOCs will be significantly elevated in diseased cohorts such that they may be characterized as on-breath in diseased populations alone. Therefore, future efforts should focus on identifying and quantifying on-breath VOCs in both heterogenous and diseased populations to build a platform for cross-population comparison.

The on-breath VOCs identified in this study can offer utility to the breath field in numerous ways: they can serve as targets for optimizing breath measurement platforms, enabling efficient and accurate identification of potential biomarkers. With appropriate controls, these VOCs may also facilitate comparison of data across studies for cross-validation of results. Furthermore, the list of VOCs can be utilized to optimize precise and accurate measurement of breath via informed selection of patient preparation, breath collection, sample storage, and sample analysis. This optimization process will preserve biological variability while minimizing technical variability, thereby advancing the reliability and reproducibility of breath-based biomarker research. This list of chemically confirmed on-breath VOCs distinguished from background contaminants lays the foundation for the development of the Breath Biopsy VOC Atlas®, an ongoing project to develop a database of chemically identified breath VOCs complete with on-breath status, and quantified reference ranges across different cohorts, including different disease states. Biological interpretation of VOCs in the breath will significantly help to confidently assign on-breath VOC status, and therefore adding mechanistic understanding of breath VOCs in the literature is important future work. Work is ongoing to build the VOC Atlas as a reference database on confirmed compounds in the breath alongside their scientific context in the literature, utilizing the robust OMNI method and the on-breath VOC list presented in this work.

Conclusion

Through the development of a robust methodology, this study collected and compared breath and background samples of a heterogenous human population to identify on-breath VOCs. These on-breath VOCs can serve as a reference for breath researchers to improve confidence that their results are capturing truly on-breath VOCs, and it will continue to expand as additional VOCs are identified using reference standards. Future work will expand the list to include a broad range of populations and physiologies to capture the diversity of on-breath VOCs. By continuing to compare background samples collected and analyzed in the same manner as their breath samples, VOCs confidently identified as being on-breath can be the basis for future biomarker investigations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Author contributions

J.G, F.vS, and W.A designed the study. W.A, S.C, A.R, E.L, E.M, M.S, A.H, S.L, C.CP, L.NS, and S.S performed the research. W.A, S.C, and O.B analyzed the data. W.A, H.C, M.B, J.G, and A.H wrote the paper. J.G, W.A, M.B, H.C, P.G, B.B, and M.A critically reviewed and revised the paper.

Declarations

Ethical statement

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. The study supporting this work was approved by the Reading Independent Ethics Committee RIEC: 290620-1.

Competing interests

BB is the CEO and Co-Founder of Owlstone Medical Ltd. WA, HC, JG, MB, OB, SC, PG, AR, EL, AH, MS, SL, EM, CCP, LND, SS, and MA are, or were employees of Owlstone Medical Ltd at the time this work was completed.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

Babu, M., & Snyder, M. (2023). Multi-omics profiling for health. Molecular & Cellular Proteomics, 22(6), 100561. 10.1016/j.mcpro.2023.100561
Carrión O Curson ARJ Kumaresan D Fu Y Lang AS Mercadé E Todd JD A novel pathway producing dimethylsulphide in bacteria is widespread in soil environments Nature Communications 2015 6 6579 10.1038/ncomms7579 25807229
Carrión, O., Curson, A. R. J., Kumaresan, D., Fu, Y., Lang, A. S., Mercadé, E., & Todd, J. D. (2015). A novel pathway producing dimethylsulphide in bacteria is widespread in soil environments. Nature Communications, 6, 6579. 10.1038/ncomms757925807229 10.1038/ncomms7579
Chou, H., Arthur, K., Shaw, E., Schaber, C., Boyle, B., Allsworth, M., Kelley, E. F., Stewart, G. M., Wheatley, C. M., Schwartz, J., Fermoyle, C. C., Ziegler, B. L., Johnson, K. A., Robach, P., Basset, P., & Johnson, B. D. (2024). Metabolic insights at the finish line: Deciphering physiological changes in ultramarathon runners through breath VOC analysis. Journal of Breath Research, 18(2). 10.1088/1752-7163/ad23f5
Costello BL Amann A Al-Kateb H Flynn C Filipiak W Khalid T Osborne D Ratcliffe NM A review of the volatiles from the healthy human body Journal of Breath Research 2014 8 1 014001 10.1088/1752-7155/8/1/014001 24421258
Costello, B. L., Amann, A., Al-Kateb, H., Flynn, C., Filipiak, W., Khalid, T., Osborne, D., & Ratcliffe, N. M. (2014). A review of the volatiles from the healthy human body. Journal of Breath Research, 8(1), 014001. 10.1088/1752-7155/8/1/01400124421258 10.1088/1752-7155/8/1/014001
Dadamio J Van den Velde S Laleman W Van Hee P Coucke W Nevens F Quirynen M Breath biomarkers of liver cirrhosis Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 2012 905 17 22 10.1016/j.jchromb.2012.07.025 22921634
Dadamio, J., Van den Velde, S., Laleman, W., Van Hee, P., Coucke, W., Nevens, F., & Quirynen, M. (2012). Breath biomarkers of liver cirrhosis. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences, 905, 17–22. 10.1016/j.jchromb.2012.07.02522921634 10.1016/j.jchromb.2012.07.025
del Fernández R O’Hara ME Holt A Pemberton P Shah T Whitehouse T Mayhew CA Volatile biomarkers in Breath Associated with Liver cirrhosis—comparisons of pre- and post-liver transplant breath samples EBioMedicine 2015 2 9 1243 1250 10.1016/j.ebiom.2015.07.027 26501124
del Fernández, R., O’Hara, M. E., Holt, A., Pemberton, P., Shah, T., Whitehouse, T., & Mayhew, C. A. (2015). Volatile biomarkers in breath associated with liver cirrhosis—comparisons of pre- and post-liver transplant breath samples. EBioMedicine, 2(9), 1243–1250. 10.1016/j.ebiom.2015.07.02726501124 10.1016/j.ebiom.2015.07.027
Di Cagno R De Angelis M De Pasquale I Ndagijimana M Vernocchi P Ricciuti P Gagliardi F Laghi L Crecchio C Guerzoni ME Gobbetti M Francavilla R Duodenal and faecal microbiota of celiac children: Molecular, phenotype and metabolome characterization BMC Microbiology 2011 11 1 219 10.1186/1471-2180-11-219 21970810
Di Cagno, R., De Angelis, M., De Pasquale, I., Ndagijimana, M., Vernocchi, P., Ricciuti, P., Gagliardi, F., Laghi, L., Crecchio, C., Guerzoni, M. E., Gobbetti, M., & Francavilla, R. (2011). Duodenal and faecal microbiota of celiac children: Molecular, phenotype and metabolome characterization. BMC Microbiology, 11(1), 219. 10.1186/1471-2180-11-21921970810 10.1186/1471-2180-11-219
Di Gilio A Palmisani J Ventrella G Facchini L Catino A Varesano N Pizzutilo P Galetta D Borelli M Barbieri P Licen S de Gennaro G Breath analysis: Comparison among methodological approaches for Breath Sampling Molecules (Basel Switzerland) 2020 25 24 5823 10.3390/molecules25245823 33321824
Di Gilio, A., Palmisani, J., Ventrella, G., Facchini, L., Catino, A., Varesano, N., Pizzutilo, P., Galetta, D., Borelli, M., Barbieri, P., Licen, S., & de Gennaro, G. (2020). Breath analysis: Comparison among methodological approaches for breath sampling. Molecules (Basel Switzerland), 25(24), 5823. 10.3390/molecules2524582333321824 10.3390/molecules25245823
Doran SLF Romano A Hanna GB Optimisation of sampling parameters for standardised exhaled breath sampling Journal of Breath Research 2017 12 1 016007 10.1088/1752-7163/aa8a46 29211685
Doran, S. L. F., Romano, A., & Hanna, G. B. (2017). Optimisation of sampling parameters for standardised exhaled breath sampling. Journal of Breath Research, 12(1), 016007. 10.1088/1752-7163/aa8a4629211685 10.1088/1752-7163/aa8a46
Drabińska, N., Flynn, C., Ratcliffe, N., Belluomo, I., Myridakis, A., Gould, O., Fois, M., Smart, A., Devine, T., & Costello, B. D. L. (2021). A literature survey of all volatiles from healthy human breath and bodily fluids: The human volatilome. Journal of Breath Research, 15(3). 10.1088/1752-7163/abf1d0
Duizer C de Zoete MR The role of Microbiota-Derived metabolites in Colorectal Cancer International Journal of Molecular Sciences 2023 24 9 8024 10.3390/ijms24098024 37175726
Duizer, C., & de Zoete, M. R. (2023). The role of microbiota-derived metabolites in colorectal cancer. International Journal of Molecular Sciences, 24(9), 8024. 10.3390/ijms2409802437175726 10.3390/ijms24098024
Ferrandino G De Palo G Murgia A Birch O Tawfike A Smith R Debiram-Beecham I Gandelman O Kibble G Lydon AM Groves A Smolinska A Allsworth M Boyle B van der Schee MP Allison M Fitzgerald RC Hoare M Snowdon VK Breath Biopsy® to identify exhaled volatile Organic compounds biomarkers for liver cirrhosis detection Journal of Clinical and Translational Hepatology 2023 11 3 638 648 10.14218/JCTH.2022.00309 36969895
Ferrandino, G., De Palo, G., Murgia, A., Birch, O., Tawfike, A., Smith, R., Debiram-Beecham, I., Gandelman, O., Kibble, G., Lydon, A. M., Groves, A., Smolinska, A., Allsworth, M., Boyle, B., van der Schee, M. P., Allison, M., Fitzgerald, R. C., Hoare, M., & Snowdon, V. K. (2023a). Breath biopsy® to identify exhaled volatile Organic compounds biomarkers for liver cirrhosis detection. Journal of Clinical and Translational Hepatology, 11(3), 638–648. 10.14218/JCTH.2022.0030936969895 10.14218/JCTH.2022.00309
Ferrandino, G., Ricciardi, F., Murgia, A., Banda, I., Manhota, M., Ahmed, Y., Sweeney, K., Nicholson-Scott, L., McConville, L., Gandelman, O., Allsworth, M., Boyle, B., Smolinska, A., Frings, G., Contreras, C. A., Asenjo-Lobos, J., Barrientos, C., Clavo, V., Novoa, N., & Méndez, A., L (2023b). Exogenous volatile organic compound (EVOC®) breath testing maximizes classification performance for subjects with cirrhosis and reveals signs of portal hypertension. Biomedicines, 11(11). 10.3390/biomedicines11112957. Article 11.
Fiehn O Robertson D Griffin J van der Werf M Nikolau B Morrison N Sumner LW Goodacre R Hardy NW Taylor C Fostel J Kristal B Kaddurah-Daouk R Mendes P van Ommen B Lindon JC Sansone SA The metabolomics standards initiative (MSI) Metabolomics 2007 3 3 175 178 10.1007/s11306-007-0070-6
Fiehn, O., Robertson, D., Griffin, J., van der Werf, M., Nikolau, B., Morrison, N., Sumner, L. W., Goodacre, R., Hardy, N. W., Taylor, C., Fostel, J., Kristal, B., Kaddurah-Daouk, R., Mendes, P., van Ommen, B., Lindon, J. C., & Sansone, S. A. (2007). The metabolomics standards initiative (MSI). Metabolomics, 3(3), 175–178. 10.1007/s11306-007-0070-610.1007/s11306-007-0070-6
Grabowska-Polanowska B Skowron M Miarka P Pietrzycka A Śliwka I The application of chromatographic breath analysis in the search of volatile biomarkers of chronic kidney disease and coexisting type 2 diabetes mellitus Journal of Chromatography B 2017 1060 103 110 10.1016/j.jchromb.2017.05.030
Grabowska-Polanowska, B., Skowron, M., Miarka, P., Pietrzycka, A., & Śliwka, I. (2017). The application of chromatographic breath analysis in the search of volatile biomarkers of chronic kidney disease and coexisting type 2 diabetes mellitus. Journal of Chromatography B, 1060, 103–110. 10.1016/j.jchromb.2017.05.03010.1016/j.jchromb.2017.05.030
Haworth JJ Pitcher CK Ferrandino G Hobson AR Pappan KL Lawson JLD Breathing new life into clinical testing and diagnostics: Perspectives on volatile biomarkers from breath Critical Reviews in Clinical Laboratory Sciences 2022 59 5 353 372 10.1080/10408363.2022.2038075 35188863
Haworth, J. J., Pitcher, C. K., Ferrandino, G., Hobson, A. R., Pappan, K. L., & Lawson, J. L. D. (2022). Breathing new life into clinical testing and diagnostics: Perspectives on volatile biomarkers from breath. Critical Reviews in Clinical Laboratory Sciences, 59(5), 353–372. 10.1080/10408363.2022.203807535188863 10.1080/10408363.2022.2038075
Herbig J Beauchamp J Towards standardization in the analysis of breath gas volatiles Journal of Breath Research 2014 8 3 037101 10.1088/1752-7155/8/3/037101 25189420
Herbig, J., & Beauchamp, J. (2014). Towards standardization in the analysis of breath gas volatiles. Journal of Breath Research, 8(3), 037101. 10.1088/1752-7155/8/3/03710125189420 10.1088/1752-7155/8/3/037101
Hewitt MJ Belluomo I Zuffa S Boshier PR Myridakis A Variation of volatile organic compound levels within ambient room air and its impact upon the standardisation of breath sampling Scientific Reports 2022 12 1 15887 10.1038/s41598-022-20365-7 36151300
Hewitt, M. J., Belluomo, I., Zuffa, S., Boshier, P. R., & Myridakis, A. (2022). Variation of volatile organic compound levels within ambient room air and its impact upon the standardisation of breath sampling. Scientific Reports, 12(1), 15887. 10.1038/s41598-022-20365-736151300 10.1038/s41598-022-20365-7
Issitt T Wiggins L Veysey M Sweeney ST Brackenbury WJ Redeker K Volatile compounds in human breath: Critical review and meta-analysis Journal of Breath Research 2022 16 2 024001 10.1088/1752-7163/ac5230
Issitt, T., Wiggins, L., Veysey, M., Sweeney, S. T., Brackenbury, W. J., & Redeker, K. (2022). Volatile compounds in human breath: Critical review and meta-analysis. Journal of Breath Research, 16(2), 024001. 10.1088/1752-7163/ac523010.1088/1752-7163/ac5230
Jia Z Patra A Kutty VK Venkatesan T Critical Review of Volatile Organic Compound Analysis in Breath and in Vitro Cell Culture for detection of Lung Cancer Metabolites 2019 9 3 52 10.3390/metabo9030052 30889835
Jia, Z., Patra, A., Kutty, V. K., & Venkatesan, T. (2019). Critical review of volatile organic compound analysis in breath and in vitro cell culture for detection of lung cancer. Metabolites, 9(3), 52. 10.3390/metabo903005230889835 10.3390/metabo9030052
Kuo TC Tan CE Wang SY Lin OA Su BH Hsu MT Lin J Cheng YY Chen CS Yang YC Chen KH Lin SW Ho CC Kuo CH Tseng YJ Human breathomics database Database: The Journal of Biological Databases and Curation 2020 2020 baz139 10.1093/database/baz139 31976536
Kuo, T. C., Tan, C. E., Wang, S. Y., Lin, O. A., Su, B. H., Hsu, M. T., Lin, J., Cheng, Y. Y., Chen, C. S., Yang, Y. C., Chen, K. H., Lin, S. W., Ho, C. C., Kuo, C. H., & Tseng, Y. J. (2020). Human breathomics database. Database: The Journal of Biological Databases and Curation, 2020, baz139. 10.1093/database/baz13931976536 10.1093/database/baz139
Louis P Flint HJ Formation of propionate and butyrate by the human colonic microbiota Environmental Microbiology 2017 19 1 29 41 10.1111/1462-2920.13589 27928878
Louis, P., & Flint, H. J. (2017). Formation of propionate and butyrate by the human colonic microbiota. Environmental Microbiology, 19(1), 29–41. 10.1111/1462-2920.1358927928878 10.1111/1462-2920.13589
Majumdar A Siva Venkatesh IP Basu A Short-chain fatty acids in the Microbiota-Gut-Brain Axis: Role in neurodegenerative disorders and viral infections ACS Chemical Neuroscience 2023 14 6 1045 1062 10.1021/acschemneuro.2c00803 36868874
Majumdar, A., Siva Venkatesh, I. P., & Basu, A. (2023). Short-chain fatty acids in the microbiota-gut-brain axis: Role in neurodegenerative disorders and viral infections. ACS Chemical Neuroscience, 14(6), 1045–1062. 10.1021/acschemneuro.2c0080336868874 10.1021/acschemneuro.2c00803
Maurer F Wolf A Fink T Rittershofer B Heim N Volk T Baumbach JI Kreuer S Wash-out of ambient air contaminations for breath measurements Journal of Breath Research 2014 8 2 027107 10.1088/1752-7155/8/2/027107 24837657
Maurer, F., Wolf, A., Fink, T., Rittershofer, B., Heim, N., Volk, T., Baumbach, J. I., & Kreuer, S. (2014). Wash-out of ambient air contaminations for breath measurements. Journal of Breath Research, 8(2), 027107. 10.1088/1752-7155/8/2/02710724837657 10.1088/1752-7155/8/2/027107
Miller TL Wolin MJ Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora Applied and Environmental Microbiology 1996 62 5 1589 1592 10.1128/aem.62.5.1589-1592.1996 8633856
Miller, T. L., & Wolin, M. J. (1996). Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Applied and Environmental Microbiology, 62(5), 1589–1592. 10.1128/aem.62.5.1589-1592.19968633856 10.1128/aem.62.5.1589-1592.1996
Mochalski, P., King, J., Mayhew, C. A., & Unterkofler, K. (2023). A review on isoprene in human breath. Journal of Breath Research, 17(3). 10.1088/1752-7163/acc964
Mochalski, P., King, J., Unterkofler, K. & Mayhew, C A. (2024). Unravelling the origin of isoprene in the humanbody—a forty year Odyssey. Journal of Breath Research, 18(3). 10.1088/1752-7163/ad4388
Ney, L. M., Wipplinger, M., Grossmann, M., Engert, N., Wegner, V. D., & Mosig, A. S. (n.d.). Short chain fatty acids: Key regulators of the local and systemic immune response in inflammatory diseases and infections. Open Biology, 13(3), 230014. 10.1098/rsob.230014
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology, 277.
Pham YL Holz O Beauchamp J Emissions and uptake of volatiles by sampling components in breath analysis Journal of Breath Research 2023 17 3 037102 10.1088/1752-7163/acce34
Pham, Y. L., Holz, O., & Beauchamp, J. (2023). Emissions and uptake of volatiles by sampling components in breath analysis. Journal of Breath Research, 17(3), 037102. 10.1088/1752-7163/acce3410.1088/1752-7163/acce34
Phillips M Method for the collection and assay of volatile organic compounds in breath Analytical Biochemistry 1997 247 2 272 278 10.1006/abio.1997.2069 9177688
Phillips, M. (1997). Method for the collection and assay of volatile organic compounds in breath. Analytical Biochemistry, 247(2), 272–278. 10.1006/abio.1997.20699177688 10.1006/abio.1997.2069
Pitcher CK Farmer AD Haworth JJ Treadway S Hobson AR Performance and interpretation of Hydrogen and Methane Breath Testing Impact of North American Consensus guidelines Digestive Diseases and Sciences 2022 67 12 5571 5579 10.1007/s10620-022-07487-8 35366119
Pitcher, C. K., Farmer, A. D., Haworth, J. J., Treadway, S., & Hobson, A. R. (2022). Performance and interpretation of hydrogen and methane breath testing impact of North American consensus guidelines. Digestive Diseases and Sciences, 67(12), 5571–5579. 10.1007/s10620-022-07487-835366119 10.1007/s10620-022-07487-8
Preter VD Machiels K Joossens M Arijs I Matthys C Vermeire S Rutgeerts P Verbeke K Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD Gut 2015 64 3 447 458 10.1136/gutjnl-2013-306423 24811995
Preter, V. D., Machiels, K., Joossens, M., Arijs, I., Matthys, C., Vermeire, S., Rutgeerts, P., & Verbeke, K. (2015). Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut, 64(3), 447–458. 10.1136/gutjnl-2013-30642324811995 10.1136/gutjnl-2013-306423
Pugliese G Trefz P Weippert M Pollex J Bruhn S Schubert JK Miekisch W Sukul P Real-time metabolic monitoring under exhaustive exercise and evaluation of ventilatory threshold by breathomics: Independent validation of evidence and advances Frontiers in Physiology 2022 13 946401 10.3389/fphys.2022.946401 36035465
Pugliese, G., Trefz, P., Weippert, M., Pollex, J., Bruhn, S., Schubert, J. K., Miekisch, W., & Sukul, P. (2022). Real-time metabolic monitoring under exhaustive exercise and evaluation of ventilatory threshold by breathomics: Independent validation of evidence and advances. Frontiers in Physiology, 13, 946401. 10.3389/fphys.2022.94640136035465 10.3389/fphys.2022.946401
Read NW Al-Janabi MN Bates TE Holgate AM Cann PA Kinsman RI McFarlane A Brown C Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrate Gut 1985 26 8 834 842 10.1136/gut.26.8.834 4018650
Read, N. W., Al-Janabi, M. N., Bates, T. E., Holgate, A. M., Cann, P. A., Kinsman, R. I., McFarlane, A., & Brown, C. (1985). Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrate. Gut, 26(8), 834–842.4018650 10.1136/gut.26.8.834
Sachdev AH Pimentel M Gastrointestinal bacterial overgrowth: Pathogenesis and clinical significance Therapeutic Advances in Chronic Disease 2013 4 5 223 231 10.1177/2040622313496126 23997926
Sachdev, A. H., & Pimentel, M. (2013). Gastrointestinal bacterial overgrowth: Pathogenesis and clinical significance. Therapeutic Advances in Chronic Disease, 4(5), 223–231. 10.1177/204062231349612623997926 10.1177/2040622313496126
Sasiene, Z. J., LeBrun, E. S., Schaller, E., Mach, P. M., Taylor, R., Candelaria, L., Glaros, T. G., Baca, J., & McBride, E. M. (2024). Real-time breath analysis towards a healthy human breath profile. Journal of Breath Research, 18(2). 10.1088/1752-7163/ad1cf1
Schubert JK Miekisch W Birken T Geiger K Nöldge-Schomburg GFE Impact of inspired substance concentrations on the results of breath analysis in mechanically ventilated patients Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 2005 10 2–3 138 152 10.1080/13547500500050259 16076729
Schubert, J. K., Miekisch, W., Birken, T., Geiger, K., & Nöldge-Schomburg, G. F. E. (2005). Impact of inspired substance concentrations on the results of breath analysis in mechanically ventilated patients. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals, 10(2–3), 138–152. 10.1080/1354750050005025916076729 10.1080/13547500500050259
Spaněl P Dryahina K Smith D A quantitative study of the influence of inhaled compounds on their concentrations in exhaled breath Journal of Breath Research 2013 7 1 017106 10.1088/1752-7155/7/1/017106 23445832
Spaněl, P., Dryahina, K., & Smith, D. (2013). A quantitative study of the influence of inhaled compounds on their concentrations in exhaled breath. Journal of Breath Research, 7(1), 017106. 10.1088/1752-7155/7/1/01710623445832 10.1088/1752-7155/7/1/017106
Sukul, P., Richter, A., Junghanss, C., Schubert, J. K., & Miekisch, W. (2023). Origin of breath isoprene in humans is revealed via multi-omic investigations. Communications Biology, 6(1). 10.1038/s42003-023-05384-y
Sumner LW Amberg A Barrett D Beale MH Beger R Daykin CA Fan TWM Fiehn O Goodacre R Griffin JL Hankemeier T Hardy N Harnly J Higashi R Kopka J Lane AN Lindon JC Marriott P Nicholls AW Viant MR Proposed minimum reporting standards for chemical analysis Metabolomics 2007 3 3 211 221 10.1007/s11306-007-0082-2 24039616
Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W. M., Fiehn, O., Goodacre, R., Griffin, J. L., Hankemeier, T., Hardy, N., Harnly, J., Higashi, R., Kopka, J., Lane, A. N., Lindon, J. C., Marriott, P., Nicholls, A. W., & Viant, M. R. (2007). Proposed minimum reporting standards for chemical analysis. Metabolomics, 3(3), 211–221. 10.1007/s11306-007-0082-224039616 10.1007/s11306-007-0082-2
van Vorstenbosch, R., Cheng, H. R., Jonkers, D., Penders, J., Schoon, E., Masclee, A., van Schooten, F. J., Smolinska, A., & Mujagic, Z. (2023). Systematic review: Contribution of the gut microbiome to the volatile metabolic fingerprint of colorectal neoplasia. Metabolites, 13(1). 10.3390/metabo13010055
Wang J Zhu N Su X Gao Y Yang R Gut-microbiota-derived metabolites maintain gut and systemic Immune Homeostasis Cells 2023 12 5 793 10.3390/cells12050793 36899929
Wang, J., Zhu, N., Su, X., Gao, Y., & Yang, R. (2023). Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis. Cells, 12(5), 793. 10.3390/cells1205079336899929 10.3390/cells12050793
Westhoff, M., Friedrich, M., & Baumbach, J. I. (2022). Simultaneous measurement of inhaled air and exhaled breath by double multicapillary column ion-mobility spectrometry, a new method for breath analysis: Results of a feasibility study. ERJ Open Research, 8(1). 10.1183/23120541.00493-2021
Westphal K Dudzik D Waszczuk-Jankowska M Graff B Narkiewicz K Markuszewski MJ Common strategies and factors affecting off-line breath sampling and volatile Organic compounds Analysis using Thermal Desorption-Gas Chromatography-Mass Spectrometry (TD-GC-MS) Metabolites 2022 13 1 8 10.3390/metabo13010008 36676933
Westphal, K., Dudzik, D., Waszczuk-Jankowska, M., Graff, B., Narkiewicz, K., & Markuszewski, M. J. (2022). Common strategies and factors affecting off-line breath sampling and volatile organic compounds analysis using thermal desorption-gas chromatography-mass spectrometry (TD-GC-MS). Metabolites, 13(1), 8. 10.3390/metabo1301000836676933 10.3390/metabo13010008
